# Critical Care Outcomes of Hematologic Oncology Patients

> **NCT03449953** · — · ACTIVE_NOT_RECRUITING · sponsor: **Mount Sinai Hospital, Canada** · enrollment: 415 (actual)

## Conditions studied

- Hematologic Malignancy
- Stem Cell Transplant

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03449953
- **Lead sponsor:** Mount Sinai Hospital, Canada
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-02-26
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 415 (ACTUAL)
- **Last updated:** 2024-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03449953

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03449953, "Critical Care Outcomes of Hematologic Oncology Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03449953. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*